Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C. [electronic resource]
Producer: 20150415Description: 1253-63 p. digitalISSN:- 1435-5922
- Aged
- Antiviral Agents -- administration & dosage
- Drug Therapy, Combination
- Embolization, Therapeutic -- methods
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- complications
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Interferons
- Interleukins -- genetics
- Liver Cirrhosis -- drug therapy
- Male
- Middle Aged
- Polyethylene Glycols -- administration & dosage
- Prognosis
- Recombinant Proteins -- administration & dosage
- Ribavirin -- administration & dosage
- Spleen -- pathology
- Splenectomy -- methods
- Thrombocytopenia -- physiopathology
- Treatment Outcome
No physical items for this record
Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.